Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Strata Critical Medical, Inc. (NASDAQ: SRTA)
SRTA Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
6.50%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
-37.10%
SRTA Stock Analysis
SRTA
PE Ratio:
11.1
SRTA
PEG Ratio:
Not Available
SRTA
Forward EPS Growth (12 month):
0.00%
SRTA
PS Ratio:
2.1
SRTA
PSG Ratio:
0.2
SRTA
Forward Revenue Growth (12 month):
9.70%
SRTA Articles
No data was found